Lataa...
Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines
NH36 is a vital enzyme of the DNA metabolism and a specific target for anti-Leishmania chemotherapy. We developed second-generation vaccines composed of the FML complex or its main native antigen, the NH36 nucleoside hydrolase of Leishmania (L.) donovani and saponin, and a DNA vaccine containing the...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6477039/ https://ncbi.nlm.nih.gov/pubmed/31040850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00813 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|